GlobeNewsWire
22 Jun 2026, 12:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
InterCure has entered a binding term sheet for a private placement providing initial funding of NIS 22 million (US$7.4 million), potentially increasing to NIS 54 million (US$18.6 million). — Immediate capital injection improves liquidity and supports the company's recovery and expansion plans.
+0.60The funding includes investment commitments from the company's CEO and institutional funds like Bennu Pharma Fund Ltd. — Insider and institutional participation serves as a strong signal of confidence in the company's long-term viability.
+0.40InterCure intends to use the proceeds to recover and expand its Nir Oz facility and accelerate growth in Germany and other regulated markets. — Concrete plans for infrastructure recovery and geographic expansion provide a roadmap for revenue growth.
+0.30Continue reading
6 related stories
Search tags
The company will issue approximately 7.9 million ordinary shares and an equal number of warrants at a premium over the June 17 closing price. — While providing cash, the issuance of millions of new shares and warrants creates significant equity dilution for existing shareholders.
-0.20The company expects to receive additional compensation for war-related damages. — Potential future cash inflows further strengthen the balance sheet beyond the private placement.
+0.20Which stocks this story touches
The company secured significant funding commitments and premium-priced investment to fuel global expansion and facility recovery.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
